Wuhan Healthgen Biotechnology Gains Approval for OsrHSA by U.S. FDA
A Wuhan-based biotechnology company in central China's Hubei province received approval by the US Food and Drug Administration for clinical trials of its OsrHSA, a recombinant human serum albumin...